InsidersTradesSigma
Browse the full record of transactions filed by Seely Lynn, Director. Insider active across 1 companies, notably Blueprint Medicines Corp. In total, 3 filings have been recorded. The latest transaction was disclosed on 21 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Lynn Seely is a Board Member at Blueprint Medicines Corp. She is involved in overseeing the company's operations and formulating strategies aimed at enhancing performance. Her expertise in the biopharmaceutical sector is beneficial for the organization.